Enhanced anti-inflammatory effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts in vitro and in vivo.
- 1 January 1997
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 14 (9) , 1223-1227
- https://doi.org/10.1023/a:1012115109525
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical Pharmacokinetics and Delivery of Bovine Superoxide DismutaseClinical Pharmacokinetics, 1995
- Delivery of a Secretable Adenosine Deaminase Through Microcapsules–A Novel Approach to Somatic Gene TherapyHuman Gene Therapy, 1994
- Human Recombinant Extracellular-Superoxide Dismutase Type C Improves Cardioplegic Protection Against Ischemia/Reperfusion Injury in Isolated Rat HeartJournal of Cardiovascular Pharmacology, 1994
- Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide DismutaseScience, 1993
- The balance between copper-zinc superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stressBiochemistry, 1991
- Cold‐induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn‐Superoxide dismutaseAnnals of Neurology, 1991
- Chemical modification of superoxide dismutase Extension of plasma half life of the enzyme through its reversible binding to the circulating albuminInternational Journal of Peptide and Protein Research, 1988
- Free radicals and myocardial ischemia: Overview and outlookFree Radical Biology & Medicine, 1988
- Clonal Gene Therapy: Transplanted Mouse Fibroblast Clones Express Human α1-Antitrypsin Gene in VivoScience, 1987
- Implantation of Genetically Engineered Fibroblasts into Mice: Implications for Gene TherapyScience, 1987